| Objective:Through the research of the subject,we understand that the patients with chronic obstructive pulmonary disease in Kunming and its surrounding area under the supervision of smoking cessation and comprehensive pulmonary rehabilitation treatment,the effect of smoking cessation,changes in lung function,6-minute walking test(6MWT),mMRC(modified Medical Research Council),CAT score(COPD Assessment Test),SGRQ score(St.George’s respiratory questionnaire),and the number of times AECOPD(Acute exacerbation of chronic obstructive pulmonary disease)readmission occurred.Methods:Collected smoking male patients diagnosed as COPD who were hospitalized from May 2018 to December 2019 in the southern campus of the Ganmei Hospital affiliated to Kunming Medical University(Kunming First People’s Hospital).After admission,the patient’s lung function was examined,and the patients were selected and identificd(Criteria:FEV1/FVC<0.7 after inhalation of bronchodilator).After doctor-patient communication,patients who have the intention to quit smoking,with the patient’s own consent,signed informed consent.To collect the information of age,height,weight,past smoking history and so on,record the pulmonary function index,6 MWT、mMRC score,CAT score,SGRQ score when entering the group(including symptom,activity and impact score).Considering the possibility of missing patients during follow-up,110 patients were expected to be enrolled.According to the order principle of 1,2,3~,the two groups were divided equally into observation group and control group.It is expected that 55 people in the control group(COPD basic medication and self-willed smoking cessation)and 55 in the observation group(Based on the control group,provide advice on smoking cessation,popularize COPD knowledge,promote lung rehabilitation training and regular telephone follow-up),including the actual number of people in the group,39 in the control group and 43 in the observation group.The pulmonary function index,6 MWT、mMRC score,CAT score,SGRQ score and the number of readmission occurred during the study period were recorded again after 6 months.Results:Age,height,weight,smoking history,smoking index and other general data of the two groups of COPD patients showed no statistical significance the difference was comparable(P>0.05).After 3 months,the number of smoking in two groups of COPD patients decreased[Observation group(11.9767±8.8358),control group(16.8462±104879)],and the difference was statistically significant.After 6 months,smoking quantity,2 groups of patients all had the decline[Observation group(12.6977±7.9897),control group(17.1026±10.4625)],before and after the difference is statistically significant(P<0.05).After March and June,the two groups of COPD patients compared with each other,the observation group was significantly better than the control group,the difference was statistically significant(P<0.05).After 3 months,the study group quit smoking 11 people,reduced smoking 10 people,22 failed.Control group quit smoking 6 people,reduce smoking 7 people,failure 26 people.Comparison after June:the observation group quit smoking 9 people,reduce smoking 13 people,failure 21 people.The control group quit smoking 4 people,reduced smoking 5 people,failure 30 people.Comparison after 6 months:2 groups of COPD patients FEV1%before and after comparison,the difference was not statistically significant(P>0.05).There was no significant difference between the two groups FEV1 COPD(P>0.05).There was no significant difference between the two groups of COPD patients before and after FVC(P>0.05).6MWT:Both the observation group and the control group were elevated[Observation group(378.0233±78.3395),control group(335.5897±79.9387)],and the difference between the two groups was statistically significant before and after COPD(P<0.05).Group 2 COPD patients compared with each other,the difference was statistically significant(P<0.05).mMRC:the observation group and the control group all had the decline[Observation group(1.4186±0.8233),control group(1.66667±0.8667)],only the observation group before and after contrast,the difference has the statistical significance(P<0.05).There was no significant difference between the two groups COPD patients(P>0.05).CAT score:The observation group and the control group had a certain degree of decline[Observation group(13.1163±4.9339)and control group(16.1538±4.8911)],but only the observation group had statistical significance(P<0.05).The difference was statistically significant COPD the two groups(P<0.05).SGRQ(symptom score):2 groups COPD patients all had the decline[Observation group(31.5419±13.6909)and control group(38.4385±14.0208)],only the observation group before and after contrast,the difference has the statistical significance(P<0.05).The difference was statistically significant COPD the two groups(P<0.05).SGRQ(activity score):The observation group and the control group all had the decline[Observation group(27.4698±10.1421)and control group(35.2795±10.9743)],only the observation group before and after contrast,the difference has the statistical significance(P<0.05).The difference was statistically significant COPD the two groups(P<0.05).SGRQ(impact score):the observation group and the control group decreased[Observation group(18.4814±13.0538),control group(23.2231±13.0834)],only the observation group before and after comparison,the difference was statistically significant(P<0.05).There was no significant difference between the two groups COPD patients(P>0.05).COPD patients with acute exacerbation were readmitted,the risk of readmission in the observation group was lower[Observation group(0.2791±0.5036),control group(0.359±0.4859)],but the difference was not statistically significant(P>0.05)Conclusion:1.The experimental group was more effective than the control group.2.The clinical symptoms of the trial group were improved and the quality of life was better than that of the control group.3.There was no significant difference in the number of readmissions between the two groups,but the risk of readmission decreased in the experimental group. |